Mouse Monoclonal Anti-SARS Spike Protein IgG |
AB-15710 |
Alpha Diagnostics |
20 ug |
EUR 489.6 |
Human IgG antibody Laboratories manufactures the sars spike protein reagents distributed by Genprice. The Sars Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Sars products are available in stock. Specificity: Sars Category: Spike Group: Protein
Protein information
SARS Biotinylated Spike RBD Recombinant Protein |
10-212 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS Associated Spike Mosaic S(M) Protein |
20-abx260155 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
SARS Associated Spike Mosaic S(N) Protein |
20-abx260157 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag) |
P1541-10 |
Biovision |
10 µg |
EUR 211.2 |
Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag) |
P1541-50 |
Biovision |
50 µg |
EUR 818.4 |
Recombinant SARS Spike Mosaic Protein S (N-Terminal) |
VAng-Lsx0073-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: SARS spike mosaic protein S (N-terminal), recombinant protein from E. coli. |
Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD) |
P1533-10 |
Biovision |
10 µg |
EUR 235.2 |
Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD) |
P1533-50 |
Biovision |
50 µg |
EUR 709.2 |
Recombinant SARS-CoV-2 Spike Protein S1 (His-tag) |
P1540-10 |
Biovision |
10 µg |
EUR 211.2 |
Recombinant SARS-CoV-2 Spike Protein S1 (His-tag) |
P1540-50 |
Biovision |
50 µg |
EUR 818.4 |
SARS (IN3) Spike Peptide |
3225P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) SARS (IN3) Spike peptide |
SARS (IN1) Spike Peptide |
3221P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) SARS (IN1) Spike peptide |
SARS (IN2) Spike Peptide |
3223P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) SARS (IN2) Spike peptide |
SARS CoV-2 full length spike protein nanodisc complex |
21-817 |
ProSci |
0.025 mg |
EUR 1968 |
Description: The coronavirus, also known as SARS-CoV-2, enters the cell by using its surface SPIKE. SPIKE is processed on the cell's surface by TMPRSS2, a serine protease. It then subsequently binds to ACE2 a cell surface receptor. The Native SPIKE protein is a trimer that is located in the coronavirus membrane. Therefore to get pure & native SPIKE the trimer needs to be kept intact. Our lab staff achieved this in three different ways: MSP nanodiscs, based on MSP proteins Detergent Mycelles, as you can see here Synthetic nanodiscs |
SARS Coronavirus spike (HSZ-Cc) Recombinant Protein |
20-219 |
ProSci |
0.1 mg |
EUR 726.9 |
Description: SARS Coronavirus spike (HSZ-Cc) Recombinant Protein |
SARS-CoV Spike Antibody |
3225-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
3225-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |